Prevalence of fragile-X syndrome and FRAXE among children with intellectual disability in a Caribbean island, Guadeloupe, French West Indies

Journal of Intellectual Disability Research

Volumn 42, Issue 1, 1998, Pages 81-89

  Elbaz, A ^a,e   Suedois J ^b   Duquesnoy, M ^c   Beldjord, C ^d   Berchel, C ^a   Merault G ^a  

^a CHU de Pointe a Pitre   (Guadeloupe)

^b Inst Médico Pedag Espoir   (Guadeloupe)

^c Service de Pédo Psychiatrie   (Guadeloupe)

^d Hôpital Cochin ^*  (France)

^e PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Caribbean; DNA analysis; Fragile X syndrome; FRAXE; Mental retardation; Screening

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; ETHNIC GROUP; FAMILY STUDY; FEMALE; FRAGILE X SYNDROME; GENETIC COUNSELING; GUADELOUPE; HUMAN; HUMAN CELL; INCIDENCE; INTELLECTUAL IMPAIRMENT; MAJOR CLINICAL STUDY; MALE; PREVALENCE; SCHOOL CHILD; SCREENING TEST;

ADOLESCENT; AFRICAN AMERICANS; AFRICAN CONTINENTAL ANCESTRY GROUP; BLOTTING, SOUTHERN; CHILD; CHROMOSOME FRAGILITY; CROSS-SECTIONAL STUDIES; FEASIBILITY STUDIES; FEMALE; FRAGILE X SYNDROME; GENETIC COUNSELING; GENETIC SCREENING; GUADELOUPE; HUMANS; INCIDENCE; MALE; MENTAL RETARDATION; PEDIGREE; POLYMERASE CHAIN REACTION;

EID: 2642703416     PISSN: 09642633     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2788.1998.00064.x     Document Type: Article

References (41)

1. Ailinghamhawkins D. J. & Ray P. N. (1995) FRAXE expansion is not a common etiological factor among developmentally delayed males. American Journal of Human Genetics 57, 72-6.
2. American College of Medical Genetics: Policy Statement (1994) Fragile X syndrome: diagnostic and carrier testing. American Journal of Medical Genetics 53, 380-1.
3. Brown W. T., Houck G. E., Jeziorowska A., Levinson F. N., Ding X., Dobkin C., Zhong N., Henderson J., Slowker Brooks S. & Jenjins E. C. (1993) Rapid fragile X carrier screening and prenatal diagnosis using a nonradioactive PCR test. JAMA 270, 1569-75.
4. Elaleem A. A., Bohm I., Temtany S., Elawady M., Awadalla M., Schmidtke J. & Stuhrmann M. (1995) Direct molecular analysis of the fragile X syndrome in a sample of Egyptian and German patients using non-radioactive PCR and Southern blot followed by chemiluminescent detection. Human Genetics 96, 577-84.
5. Fryns J. P. (1995) Screening for the fragile X syndrome: the necessity of international guidelines for molecular genetics predictive testing in general. Genetic counselling, 6, 293-296.
6. Fu Y. H., Kuhl D. P. A., Pizzuti A., Pieretti M., Sutcliffe J. S., Richards S., Verkerk A. J. M. H., Holden J. J. A., Fenwick R. G., Jr, Warren S. T., Oostra B. A., Nelson D. L. & Caskey C. T. (1991) Variation of the CGG repeat at the fragile X site in genetic instability: resolution of the Sherman paradox. Cell 67, 1047-58.
7. Hagerman R. J., Khalid A. & Cronister A (1991) Fragile X check list. American Journal of Medical Genetics 43, 283-7.
8. Hirtzlin H., Mandel J. L., Lanoé J. L. & Fardeau-Gautier M. (1995) Analyse comparée du coût des techniques cytogénétiques et de biologie molécukaire dans le diagnostic de la maladie de l'X fragile. Revue d'Epidémiologie et Santé Publique 43, 205-14.
9. Howard-Peebles P. N. & Stoddard G. R. (1980) Race distribution in X-linked mental retardation with macroorchidism and fragile site in Xq. American Journal of Human Genetics 32, 629-30.
10. Jacobs P. A., Bullman H., Macpherson J., Youings S., Rooney V., Watson A. & Dennis N. R. (1993) Population studies of the fragile X: a molecular approach. Journal of Medical Genetics 30, 454-9.
11. Knight S. J. L., Flannery A. V., Hirst M. C., Campbell L., Christodoulou Z., Phelps S. R., Pointon J., Middleton-Price H. R., Barnicoat A., Pembrey M. E., Holland J., Oostra B. A., Bobrow M. & Davies K. E. (1993) Trinucleotide repeat amplification and hypermethylation of a CpG island in FRAXE mental retardation. Cell 74, 127-34.
12. Knight S. J. L., Ritchie R. J., Chakrabarti L., Cross G., Taylor G. R., Mueller R. F., Hurst J., Paterson J., Yates J. R. W., Dow D. J. & Davies K. E. (1996) A study of FRAXE in mentally retarded individuals referred for Fragile X syndrome (FRAXA) testing in the united kingdom. American Journal of Human Genetics 58, 906-13.
13. Krahe R., Eckhart M., Ogunniyi A. O., Osuntokun B. O., Siciliano M. J. & Ashizawa T. (1995) De novo myotonic dystrophy mutation in a Nigerian kindred. American Journal of Human Genetics 56, 1067-74.
14. Laing S., Partington M., Robinson H. & Turner G (1991) Clinical screening score for the Fragile X (Martin Bell). Journal of Medical Genetics 38, 256-9.
15. Malmgren H., Gustavson K. H., Oudet C., Holmgren G., Petterson U. & Dahl N. (1994) Strong founder effect for the fragile X syndrome in Sweden. European Journal of Human Genetics 2, 103-9.
16. Mandel J. L., Biancalana V., Bouix J. C. & Cossée M. (1994) Screening for the fragile X mental retardation syndrome. In: New Horizons in Neonatal Screening (eds J. P. Farriaux & J. L. Dhondt), pp. 261-272. Elsevier Science, Amsterdam.
17. Oberlé I., Rousseau F., Heitz D., Kretz C., Devys D., Hanauer A., Boué J., Bertheas M. F. & Mandel J. L. (1991) Instability of a 550-base pair DNA segment and abnormal methylation in fragile X syndrome. Science 252, 1097-102.
18. Oostra B. A., Jacky P. B., Brown T. & Rousseau F. (1993) Guidelines for the diagnosis of fragile X syndrome. Journal of Medical Genetics 40, 410-13.
19. Oudet C., Mornet E., Serre J. L., Thomas F., Lentes-Zengerling S., Kretz C., Deluchat C., Tejada I., Boué J., Boué A. & Mandel J. L. (1993a) Linkage disequilibrium between the fragile X mutation and two closely linked CA repeats suggest that fragile X chromosomes are derived from a small number of founder chromosomes. American Journal of Human Genetics 52, 297-304.
20. Oudet C., von Koskull H., Nordström A. M., Peippo M. & Mandel J. L. (1993b) Striking founder effect for the fragile X syndrome in Finland. European Journal of Human Genetics 1, 181-9.
21. Richards R. I., Holman K., Friend K., Kremer E., Hillien D., Staples A., Brown W. T., Goonewardena P., Tarleton J., Schwartz C. & Sutherland G. R. (1992) Evidence of founder chromosomes in fragile X syndrome. Nature Genetics 1, 257-60.
22. Rousseau F., Heitz D., Biancalana V., Blumenfeld S., Kretz C., Boué J., Tommerup N., Van Der Hagen K., DeLozier-Blanchet C., Croquette M. F., Gilgenkrantz S., Jalbert P., Voelckel M. A., Oberlé I. & Mandel J. L. (1991) Direct diagnosis by DNA analysis of the fragile X syndrome of mental retardation. New England Journal of Medicine 325, 673-81.
23. Rousseau F., Rouillard P., Morel M. L., Khandijan E. W. & Morgan K. (1995) Prevalence of carriers of premutation-size alleles of the FMR1 gene-and implications for population genetics of the fragile X syndrome. American Journal of Human Genetics 57, 1006-18.
24. Rumeau-Rouquette C. (1995) Recherche épidémiologique sur les handicaps de l'enfant. Revue d'Epidemiologie et Santé Publique 43, 201-3.
25. Rumeau-Rouquette C., du Mazaubrun C., Verrier A. & Mlika A. (1994) Prévalence des handicaps. Evolution dans trois générations d'enfants 1972, 1976 (1981). INSERM-Doin, Paris.
26. Sabaratnam M., Laver S., Butler L. & Pembrey M. (1994) Fragile-X syndrome in North East Essex: towards systematic screening: clinical selection. Journal of Intellectual Disability Research 38, 27-35.
27. Sherman S. (1991) Epidemiology. In: Fragile X Syndrome: Diagnosis, Treatment and Research (eds R. J. Hagerman & A. C. Sylverman), pp. 69-97. Johns Hopkins University Press, Baltimore, MD.
28. Slaney S. F., Wilkie A. O. M., Hirst M. C., Charlton R., McKinley M., Pointon J., Christodoulou Z., Huson S. M. & Davies K. E. (1995) DNA testing for fragile X syndrome in schools for learning difficulties. Archives of Disease in Childhood 72, 33-7.
29. Squitieri F., Andrew S. E., Goldberg Y. P., Kremer B., Spencc N., Zeisler J., Nichol K., Theilmann J., Greenberg J., Goto J., Kanazawa I., Vesa J., Peltonen L., Almqvist E., Anvret M., Helenius H., Lin B., Napolitano G., Morgan K. & Hayden M. R. (1994) DNA haplotype analysis of Huntington disease reveals clues to the origins and mechanisms of CAG expansion and reasons for geographic variations of prevalence. Human Molecular Genetics 3, 2103-14.
30. Thake A., Todd J., Bundey S. & Webb T. (1985) It is possible to make a clinical diagnosis of the fragile X syndrome in boys? Archives of Disease in Childhood 60, 1001-7.
31. Turner G., Robinson H., Laing S., Van Den Berk M., Colley A., Goddard A., Sherman S. & Partington A. (1992) Population screening for fragile X. Lancet 339, 1210-13.
32. Van der Ouweland A. M. W., de Vries B. B. A. & Bakker P. L. G. (1994) DNA diagnosis of the fragile X syndrome in a series of 236 mentally retarded subjects and evidence for a reversal of mutation in the FMR-1 gene. American Journal of Medical Genetics 51, 482-5.
33. Venter P. A., Gericke G. S., Dawson B. & Op't Hof J. (1981) A marker X chromosome associated with non-specific male retardation. South African Medical Journal 60, 807-11.
34. Venter P. A. & Op't Hof J. (1982) Cytogenetic abnormalities including the marker X chromosome in patients with severe mental retardation. South African Medical Journal 62, 947-50.
35. Verkerk A. J. M. H., Pieretti M., Sutcliffe J. S., Fu Y. H., Kuhl D. P. A., Pizzuti A., Reiner O., Richards S., Victoria M. F., Zhang F., Eussen B. E., van Ommen G. J. B., Blonden L. A., Riggins G. J., Chastain J. L., Kunst C. B., Galjaard H., Caskey C. T., Nelson D. L., Oostra B. A. & Warren S.T (1991) Identification of a gene (FMR1) containing a CGG repeat coincident with a fragile X breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell 65, 905-14.
36. Wang Q., Green E. & Barnicote A. (1993) Cytogenetic vs. DNA diagnosis in routine referrals for the fragile X syndrome. Lancet 342, 1025-6.
37. Wang Q., Green E., Bobrow M. & Mathew C. (1995) A rapid, non-radioactive screening test for fragile X mutations at the FRAXA and FRAXE loci. Journal of Medical Genetics 32, 170-3.
38. Warren S. T. & Nelson D. L. (1994) Advances in molecular analysis of fragile X syndrome. JAMA 271, 536-42.
39. Webb T. (1991) The epidemiology of fragile X syndrome. In: The Fragile X Syndrome (ed. K. E. Davies), pp. 40-54. Oxford University Press, Oxford.
40. Yu S., Pritchard M., Kremer E., Lynch M., Nancarrow J., Baker E., Holman K., Mulley J. C., Warren S. T., Schlessinger D., Sutherland G. R. & Richards R. I. (1990 Fragile X genotype characterized by an unstable region of DNA. Science 252, 1179-81.
41. Zerilnick C., Torroni A., Sherman S. L. & Warren S. T. (1995) Normal variation at the myotonic dystrophy locus in global human populations. American Journal of Human Genetics 56, 123-30.